The venture firm, backed by Mayo Clinic for its first fund, is reportedly seeking $350m to $500m for its sophomore vehicle.

Ince Capital, a China-based venture capital firm backed by medical researcher and care provider Mayo Clinic, is close to raising up to $500m for a second fund, Bloomberg has reported. The firm raised $352m for its debut fund in late 2019 from LPs including Mayo Clinic and endowment funds from institutions including the University of…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.